Coffee Beats Microdosing LSD for Depression Treatment

The Silicon Valley wellness trend of microdosing psychedelics just hit a major roadblock, and the winner might be sitting in your kitchen cabinet.

Melbourne-based MindBio Therapeutics just completed what researchers are calling the most rigorous microdosing trial ever conducted. The results? A regular cup of coffee outperformed tiny doses of LSD in treating major depressive disorder.

The eight-week study followed 89 adults with clinical depression. Some received microdoses of LSD (4 to 20 micrograms, far below a hallucinogenic dose), while others got caffeine pills as a placebo. Surprisingly, the coffee group showed better results on standard depression rating scales.

"It's probably a nail in the coffin of using microdosing to treat clinical depression," says MindBio CEO Justin Hanka. While microdosing did improve how depressed people felt, the changes weren't significant enough to matter clinically.

The findings align with growing skepticism about microdosing's actual benefits. In 2020, researcher Jay Olson at McGill University gave 33 people fake psychedelics and told them it was real. Most reported feeling drug effects anyway, even though they'd taken nothing at all.

"The public has a lot of misconceptions about the placebo effect," explains Olson, now at the University of Toronto. "There's this assumption that placebo effects are extremely weak, or that they're not real."

The hype surrounding psychedelics may actually boost placebo effects. When people expect a transformative experience, their minds can sometimes create one. This doesn't mean the positive feelings aren't real, just that they might come from expectation rather than the drug itself.

The Bright Side

This news isn't all disappointing. First, it validates something millions already know: coffee genuinely helps mood and focus. Your morning ritual has science on its side.

More importantly, the research demonstrates honest, rigorous science in action. MindBio could have buried disappointing results, but instead chose transparency. That's how we separate real treatments from false hope.

The study also doesn't affect research into full-dose psychedelic therapy, which shows more promising results for depression and PTSD. Scientists are still exploring how standard doses of psilocybin and MDMA, administered in clinical settings, might help mental health conditions.

For anyone struggling with depression, the message is clear: proven treatments like therapy, medication, and yes, even your daily coffee, deserve attention before experimental microdosing. Sometimes the simplest solutions work best.

Science just gave us permission to enjoy our coffee guilt-free, knowing it's doing real good.